SCHEMBL21731364

SCHEMBL21731364

COc1ccc(F)cc1C(C)c1cc2ccccc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.46
▸ MAPT P10636 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ NR3C1 P04150 3/20 0.43
▸ PGR P06401 3/20 0.43
▸ NR3C2 P08235 3/20 0.43
▸ FLT3 P36888 2/20 0.40
▸ ALOX5 P09917 1/20 0.39
▸ IDO1 P14902 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ SENP8 Q96LD8 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23521842 0.86 KDM4E (0.45) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL23543166 0.86 KDM4E (0.45) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL29662251 0.86 KDM4E (0.45) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL23521838 0.86 KDM4E (0.45) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL23521919 0.86 KDM4E (0.45) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL30116302 0.77 NR3C1 (0.40) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL27205350 0.77 NR3C1 (0.40) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL24737106 0.77 NR3C1 (0.40) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL27176496 0.77 NR3C1 (0.40) KDM4EMAPTRAB9AMEN1ALDH1A1
SCHEMBL23522145 0.76 KDM4E (0.51) KDM4EMAPTRAB9AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020036386-A1 ISOINDOLIN-1-ON DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE COMPONENT FOR PREVENTING OR TREATING CANCER 한국화학연구원 2020-02-20 — — WO disclosed
Send feedback